These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26544968)

  • 41. Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
    Uratani R; Toiyama Y; Shimura T; Mori K; Fujikawa H; Hiro J; Ohi M; Inoue Y; Tanaka K; Araki T; Mohri Y; Kusunoki M
    Anticancer Res; 2015 Oct; 35(10):5639-48. PubMed ID: 26408737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer.
    Kishiki T; Masaki T; Matsuoka H; Kobayashi T; Suzuki Y; Abe N; Mori T; Sugiyama M
    Am J Surg; 2013 Aug; 206(2):234-40. PubMed ID: 23827511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
    Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
    Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of preoperative platelet count in patients with gallbladder cancer.
    Wang RT; Zhang LQ; Mu YP; Li JB; Xu XS; Pang Q; Sun LK; Zhang X; Dong SB; Wang L; Liu C
    World J Gastroenterol; 2015 May; 21(17):5303-10. PubMed ID: 25954104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
    Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.
    Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
    Br J Surg; 2007 Aug; 94(8):1028-32. PubMed ID: 17437250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Eur J Cancer; 2009 Aug; 45(12):2138-45. PubMed ID: 19409772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of operative risk in colorectal cancer surgery: the Cleveland Clinic Foundation colorectal cancer model.
    Fazio VW; Tekkis PP; Remzi F; Lavery IC
    Dis Colon Rectum; 2004 Dec; 47(12):2015-24. PubMed ID: 15657649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
    Lee SM; Russell A; Hellawell G
    Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor].
    Herold Z; Ambrus V; Herold M; Herczeg G; Igaz P; Harsányi L; Somogyi A
    Orv Hetil; 2018 May; 159(19):756-767. PubMed ID: 29730943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.
    Richards CH; Roxburgh CS; MacMillan MT; Isswiasi S; Robertson EG; Guthrie GK; Horgan PG; McMillan DC
    PLoS One; 2012; 7(8):e41883. PubMed ID: 22870258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.
    Richards CH; Flegg KM; Roxburgh CS; Going JJ; Mohammed Z; Horgan PG; McMillan DC
    Br J Cancer; 2012 Jun; 106(12):2010-5. PubMed ID: 22596238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship Between Co-morbidity, Screen-Detection and Outcome in Patients Undergoing Resection for Colorectal Cancer.
    Johnstone MS; McMillan DC; Horgan PG; Mansouri D
    World J Surg; 2021 Jul; 45(7):2251-2260. PubMed ID: 33774690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preoperative platelet count and colorectal cancer recurrence].
    Padilla D; Cubo T; Pardo R; Molina JM; Martín J; Hernández J
    Rev Esp Enferm Dig; 2004 Oct; 96(10):733-4. PubMed ID: 15537381
    [No Abstract]   [Full Text] [Related]  

  • 60. The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score.
    Dolan RD; McMillan DC
    Crit Rev Oncol Hematol; 2020 Jun; 150():102962. PubMed ID: 32344318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.